Statistics for Lexaria Bioscience Corp. (id:6130 LEXX)

Valuation metrics

Market cap

37.87M

Enterprise value

24.30M

Trailing P/E (ttm)

-2.07

Forward P/E

-5.56

PEG ratio

-5.56

Price/Sales (ttm)

92.14

Price/Book (mrq)

3.39

Enterprise Value/Revenue

59.13

Enterprise Value/EBITDA

-5.36

Overview

Shares outstanding

17.45M

Float

13.23M

Shares short

277.08K

% Held by insiders

0.07%

% Held by institutions

0.06%

Average volume (10 days)

163.08K

Average volume (90 days)

Price summary

52-Week low

1.20

52-Week high

6.85

52-Week change

37.32%

Beta

1.06

50-Day moving average

2.82

200-Day moving average

3.03

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

January 12th, 2021

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

August 31th, 2023

Most recent quarter (mrq)

May 31th, 2024

Profitability

Profit margin

86.07%

Operating margin

-2,074.90%

Operational effectiveness

Return on assets

-38.21%

Return on equity

-70.66%

Income statement

Revenue (ttm)

0.04

Revenue per share (ttm)

0.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

194.71K

EBITDA

-4,533,468.00

Net income to common (ttm)

-4,849,874.00

Diluted EPS (ttm)

-0.44

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

8.51M

Total cash per share (mrq)

0.54

Total debt (mrq)

142.59K

Total Debt/Equity (mrq)

1.46

Current ratio (mrq)

5.83K%

Book value per share (mrq)

0.64

Cash flow

Cash flow statement

-4,689,024.00

Levered free cash flow (LFCF)

-3,212,450.00